Antiphospholipid Syndrome

This is a condition where your body makes antibodies against certain fats called phospholipids. These antibodies can cause blood clots, which can lead to serious problems like stroke or heart attack. It can also affect pregnancy, causing miscarriages. Doctors check for specific antibodies in your blood to diagnose it.

Condition

What people with Antiphospholipid Syndrome report

Every report comes from a Lived member, sent anonymously.

Have you tried Coumadin (Warfarin) for Antiphospholipid Syndrome?

NameHow it went

About Antiphospholipid Syndrome

What It Is

Antiphospholipid syndrome (APS) is an autoimmune disorder that makes the blood more likely to clot when it shouldn't. The immune system produces antibodies, called antiphospholipid antibodies, that act on the body's own proteins and cells and switch on clotting. It is also known as Hughes syndrome. These clots can form in almost any blood vessel. In a vein, usually in the leg, a clot is called a deep vein thrombosis, and part of it can break off and travel to the lungs (a pulmonary embolism). In an artery, a clot can cause a stroke or heart attack. APS also affects pregnancy: it can lead to repeated miscarriages, pregnancy loss later on, preeclampsia (high blood pressure in pregnancy) and a placenta that doesn't supply the baby well. A clot or a pregnancy complication is usually the first sign. Some people also have a low platelet count, a lacy purplish pattern on the skin of the legs or arms, or problems with heart valves. APS can occur on its own or alongside another autoimmune disease, most often lupus. Testing positive for these antibodies without ever having a clot or pregnancy complication is not the same as having APS, although it does raise the risk of a first clot.

Causes & Risk Factors

Why some people make antiphospholipid antibodies is not well understood. Most cases don't run in families, though genes probably contribute. Some infections, including HIV, hepatitis C and the bacterium that causes Lyme disease, can prompt these antibodies. APS is more common in women, who make up about 7 in 10 people diagnosed, and it usually appears in early to mid-adulthood. Lupus is the biggest single association: roughly 20% to 30% of people with lupus have the antibodies, though having them does not mean a clot will follow. It helps to separate the underlying tendency from what sets off a particular clot. The antibodies raise the baseline risk, and the type and amount matter: people who test positive on all three antibody tests (called triple positive) at consistently high levels carry the highest risk. A clot is then more likely when other factors add to that risk, such as smoking, high blood pressure, obesity, hardening of the arteries, estrogen-containing birth control, pregnancy and the weeks after giving birth, surgery or long periods without moving.

How It's Diagnosed

APS is diagnosed when two things come together: a clinical event, such as a clot in a vein or artery or a characteristic pregnancy complication, and antiphospholipid antibodies in the blood that persist over time. Neither one alone is enough. Three blood tests look for the antibodies. Lupus anticoagulant is measured with a clotting test in the lab. Anticardiolipin and anti-beta-2 glycoprotein I antibodies are measured directly. A positive result has to be confirmed on a repeat test at least 12 weeks (about three months) later, since only antibodies that persist count toward the diagnosis. Clinicians then look at the overall antibody profile: which tests are positive, how many of the three, and how high the levels are. This profile, along with whether past clots were in veins or arteries, shapes how intensive treatment needs to be. Testing is often considered after a clot with no clear cause, a stroke at a young age or repeated pregnancy losses. Care is usually led by a hematologist (a blood specialist) or a rheumatologist, with an obstetric team involved during pregnancy.

Treatment Options

There is no cure for APS, but treatment can greatly lower the chance of new clots and of pregnancy complications. The right plan depends on what has happened before and on the antibody profile. After a clot, the core treatment is an anticoagulant (blood thinner). People usually start with heparin, given by IV or as injections of a form such as enoxaparin (Lovenox), and then move to warfarin, a pill that works by blocking vitamin K, which is why vitamin K in food can affect it. Warfarin's dose is adjusted using the INR (international normalized ratio), a blood test of how quickly blood clots; a higher number means slower clotting and more protection, but also more bleeding risk. After a first clot in a vein, the usual target is an INR of 2 to 3, and when the clot had no obvious trigger, treatment is generally continued long term. After a clot with a clear trigger, how long treatment lasts depends on the antibody profile and other risks. After a clot in an artery, some specialists aim for 2 to 3 and others for 3 to 4 or add low-dose aspirin, weighing clot risk against bleeding risk. Warfarin's main trade-offs are regular INR checks and the fact that other medicines and changes in diet can shift the INR. Newer pills called direct oral anticoagulants, such as rivaroxaban (Xarelto), don't need INR monitoring, but they work less well in APS. The FDA label says they are not recommended for people who are triple positive, because of higher rates of repeat clots compared with warfarin, and European specialist guidelines advise against them after an artery clot. They may be considered only in selected people who cannot take warfarin. For people with high-risk antibodies who have never had a clot, low-dose aspirin may be recommended; in observational studies it was linked to about half the risk of a first clot. Pregnancy needs its own plan. Women with past APS pregnancy complications are usually treated with low-dose aspirin plus heparin injections during pregnancy, and women who have had a clot take a higher, full-strength heparin dose. Warfarin can harm a developing baby, so it is switched to heparin as soon as pregnancy is confirmed, ideally before the sixth week. Heparin is often continued for about six weeks after delivery, when clot risk is still high. If complications recur despite this, options include a higher heparin dose or adding hydroxychloroquine, an antimalarial medicine also used for lupus. Lowering other clot risks is part of treatment too: not smoking, managing blood pressure and weight, and generally avoiding estrogen-containing birth control or menopausal hormone therapy unless a physician directs. Because APS is rare, large trials are few, and specialists sometimes differ on the best approach.

What to Expect

APS is usually long-lasting, and many people who have had a clot take a blood thinner for the rest of their lives. Daily life on warfarin means regular INR blood tests, keeping diet fairly consistent, and checking with the care team before starting or stopping other medicines or supplements. Any planned surgery or procedure that requires pausing a blood thinner should be planned in advance with the clinician who manages the anticoagulation. Stopping anticoagulation, along with infections and surgery, is one of the most common triggers of catastrophic APS, a rare (under 1% of people with APS) but life-threatening form in which clots form in several organs at once. Pregnancy is possible for many women with APS, but it works best when planned with the care team before conception, so that medicines can be changed in time and the pregnancy can be monitored closely. In observational studies of women with a history of clots treated with aspirin and full-strength heparin, about 4 in 5 pregnancies ended in a live birth.

When to Seek Help

Ask about antiphospholipid antibody testing if you have had a blood clot without a clear cause, a stroke at a young age or repeated pregnancy losses, and talk with your care team before trying to conceive if you have APS or take warfarin. Call your care team right away if one leg or arm becomes swollen, painful, warm or red, if you notice unusual bleeding or bruising while on a blood thinner, or if you become pregnant while taking warfarin. Check with them before stopping any blood thinner, even briefly. Call 911 for sudden shortness of breath, chest pain or coughing up blood, which can mean a clot in the lungs or a heart attack, or for sudden weakness or numbness on one side, trouble speaking, sudden loss of vision or a sudden severe headache, which can signal a stroke.

Questions to Ask Your Doctor

  1. 1.What does my antibody profile, including whether I am triple positive, mean for my risk and my treatment?
  2. 2.How long will I need a blood thinner, and why is this one the right choice for me?
  3. 3.What INR range are we aiming for, and how often should it be checked?
  4. 4.How should we plan for a future pregnancy, or for surgery or other procedures, so my clot protection isn't interrupted?
  5. 5.Are there other conditions, such as lupus, that we should test for or manage alongside APS?

Last reviewed • Oct 2026

Educational content, not medical advice.